ALPHABETA AB has a total of 23 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MOUNTGATE GROUP LTD, ROHLFF CHRISTIAN and BIOREALITES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 3 | |
#5 | Canada | 2 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Johansson Jan | 22 |
#2 | Presto Jenny | 6 |
#3 | Dolfe Lisa | 4 |
#4 | Strömberg Roger | 4 |
#5 | Maity Jyotirmoy | 4 |
#6 | Juneja Alok | 4 |
#7 | Nilsson Lennart | 4 |
#8 | Kurudenkandy Firoz Roshan | 4 |
#9 | Sargsyan Hasmik | 4 |
#10 | Honcharenko Dmytro | 4 |
Publication | Filing date | Title |
---|---|---|
JP2016094422A | Compound and method for treating alzheimer's disease and familial dementia | |
WO2015107170A1 | Novel ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide | |
AU2010356144A1 | Compound and method for treatment of Alzheimer's disease and familial dementia | |
AU2006217544A1 | Compounds for reducing aggregation of amyloid beta-peptide | |
US6716589B2 | Discordant helix stabilization for prevention of amyloid formation |